14K → 13K shares held−8% of their stake
Becton Dickinson's & Pres Med.Essntl&BioPharm sold $160K of Becton Dickinson shares. Nobody planned it ahead of time.
Traded May 26, 2026 · Filed May 27, 2026
Becton Dickinson's Chief Revenue Officer sold $11K of Becton Dickinson shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$11,051
Shares × reported transaction price
19 days after results of May 7, 2026, 72 days before results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $147.75 on May 26, 2026, within 4% of its 52-week low, after a 5% drop over the previous 30 trading days
52-week range $142.35 (May 18, 2026) to $210.02 (Feb 6, 2026), 8% of the way up, from 251 adjusted closes. 30 trading days earlier: $155.43 on Apr 13, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.8% | +0.3% | +0.4% |
| 30 days | +4.6% | -1.8% | +6.4% |
| 90 days | +28.2% | +1.5% | +26.6% |
Past results only. Not a forecast.
14K → 13K shares held−8% of their stake
Becton Dickinson's & Pres Med.Essntl&BioPharm sold $160K of Becton Dickinson shares. Nobody planned it ahead of time.
3 different filers disclosed BDX within 90 days. Disclosed 28 days after the transaction; reported as an official range, not an exact amount.
Officer sold ~$167K of Becton Dickinson
Automatic sale